HARROW HEALTH, INC. Purchase Agreements
17 Contracts & Agreements
- Asset Purchase Agreement dated December 13, 2022, between the Company and Novartis Technology, LLC and Novartis Innovative Therapies AG (Filed With SEC on December 14, 2022)
- Asset Purchase Agreement, dated as of December 17, 2021, by and between the Company and Novartis Technology, LLC and Novartis Ophthalmics AG (Filed With SEC on March 10, 2022)
- Basic Sale and Purchase Agreement, dated as of August 18, 2021, by and between the Company and Wakamoto Pharmaceutical Co., Ltd (Filed With SEC on November 9, 2021)
- Securities Purchase Agreement, dated as of May 5, 2021, by and between the Company and B. Riley Securities, Inc (Filed With SEC on May 5, 2021)
- Asset Purchase Agreement, dated July 26, 2019, by and between Park Compounding, Inc. and Noice Rx, LLC (Filed With SEC on November 13, 2019)
- Asset Purchase Agreement dated February 1, 2019 between Harrow Health, Inc. and Elle Pharmaceuticals, Inc (Filed With SEC on May 9, 2019)
- Asset Purchase Agreement dated February 1, 2019 between Harrow Health, Inc. and Mayfield Pharmaceuticals, Inc (Filed With SEC on May 9, 2019)
- Asset Purchase Agreement dated December 11, 2018 between Imprimis Pharmaceuticals, Inc. and Melt Pharmaceuticals, Inc (Filed With SEC on February 5, 2019)
- Amend and Restated Asset Purchase and License Agreement dated April 10, 2018 between Imprimis Pharmaceuticals, Inc. and Surface Pharmaceuticals, Inc (Filed With SEC on May 15, 2018)
- Asset Purchase and License Agreement dated September 28, 2017 between Imprimis Pharmaceuticals, Inc. and Surface Pharmaceuticals, Inc (Filed With SEC on May 15, 2018)
- AMENDMENT TO ASSET PURCHASE AGREEMENT (Filed With SEC on March 28, 2014)
- AMENDMENT TO ASSET PURCHASE AGREEMENT (Filed With SEC on March 28, 2014)
- MEMBERSHIPINTEREST PURCHASE AGREEMENT among JOHNSCOTT KAROLCHYK and BERNARD COVALESKY and IMPRIMISPHARMACEUTICALS, INC. datedas of February10, 2014 (Filed With SEC on February 11, 2014)
- FIRST AMENDED SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 25, 2012)
- EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 27, 2012)
- Exhibit 10.4 SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 20, 2011)
- ASSET PURCHASE AGREEMENT DATED AS OF JUNE 26, 2011 BY AND AMONG TRANSDEL PHARMACEUTICALS, INC., AS SELLER AND CARDIUM HEALTHCARE, INC., AS PURCHASER AND CARDIUM THERAPEUTICS INC. (Filed With SEC on June 27, 2011)
